←
David S. Hong MD2,670 posts
David S. Hong MD avatar✓

David S. Hong MD ✓

@DavidHongMD

MD Anderson Cancer Center medical oncologist, Deputy Chair of Dept. Investigational Cancer Therapeutics. Phase I clinical trials.Tweets are mine.

◷ Joined February 2016▧ 380 Photos and videos
David S. Hong MD avatar
David S. Hong MD@DavidHongMD·Nov 16

We have a tradition in ICT. We welcome our faculty who have not been in Texas with the best food on the planet-Texas BBQ and the best shoes on the planet-cowboy boots! Welcome Dr Baldini!

Post attachmentPost attachment
Stephen V Liu, MD avatar
⟳ David S. Hong MD retweeted
Stephen V Liu, MD@StephenVLiu·Nov 14

So grateful to all who helped make the MedStar Health Wine and Dine such a big success - including the singular @eunyangnbc and all the amazing people at Four Seasons and Bourbon Steak DC. Coming together to support lung cancer research - such an impactful event. @MedStarHealth

Post attachmentPost attachmentPost attachmentPost attachment
David S. Hong MD avatar
David S. Hong MD@DavidHongMD·Nov 14

Stuck in Toronto for a day bc of the whole FAA shutdown but had a chance to see the city and taste the amazing food!

Post attachmentPost attachmentPost attachment
Michel Doepke avatar
⟳ David S. Hong MD retweeted
Michel Doepke@doepke_michel·Nov 12

I'd like to share this slide again. We've reached a point where the treatment of PDAC is undergoing a paradigm shift. We're only at the beginning - and we'll see even better data. In my opinion, combination studies are the way forward. Time will tell. $TNGX $RVMD $ERAS

Post attachment
Wungki Park, MD MS avatar
⟳ David S. Hong MD retweeted
Wungki Park, MD MS@CentralParkWMD·Nov 12

🎬 Lights. Camera. Science! 🧬 A little behind the scenes with 🇰🇷 EBS documenting the people and science driving the next era of cancer therapeutics at @MSKCancerCenter @DanaFarber @VUMCDiscoveries @yonsei_u From #KRAS breakthroughs to translational research and the HUMAN stories behind every discovery. Science is a team sport! 🤝 More to come! 🎥 in January! TBD #PancreaticCancer #RAS #HBP #sPARKLab @CpcrMsk @MSK_DeptOfMed @MSKCancerCenter @nasca_vincenzo @ldiaz1971

Post attachmentPost attachmentPost attachmentPost attachment
KRAS Kickers avatar
⟳ David S. Hong MD retweeted
KRAS Kickers@KRASKickers·Nov 6

Please retweet - OR please send your message of hope OR both! Feel free to screenshot your messages! All messages will be collected as part of this shared expression of hope. @DrDanielKing @DavidHongMD @GarridoLagunaMD @kevansf @Sandra_Misale @EileenMOReilly @BHuffmanMD @BiachiTiago @MPishvaian @AmbrogioLab @FilippoPietran4 @DrShubhamPant @GIcancerDoc @DrMarkAwad @cjder23 @norbertkraut1 @CentralParkWMD @Aiims1742

Post attachmentPost attachmentPost attachment
Adam C Palmer avatar
⟳ David S. Hong MD retweeted
Adam C Palmer@ac_palmer·Nov 2

With many new cancer medicines, reminder that the clinical effectiveness of drug combinations is highly predictable from the clinical effectiveness of single agents 100% sensitive prediction of phase 3 trial success across all advanced cancers, 1995-2020 nature.com/articles/s43018-0…

Ruxandra Teslo 🧬 avatar
⟳ David S. Hong MD retweeted
Ruxandra Teslo 🧬@RuxandraTeslo·Oct 27

Despite staggering advances in basic science, drug development research is only getting slower. The main culprit? Increasing clinical trial timelines. The median clinical development pathway has increased from 8.4 years to 9.3 years and pipeline creation has slowed 32% even as R&D spend has gone up. This is the point I keep making about the main bottleneck to drug discovery and why AI on its own won't be enough. These timelines aren't going anywhere (ofc AI can be used creatively to ease such bottlenecks -- eg via better endpoints that allow smaller cohorts for trials, followed up for shorter periods of time).

Post attachment